← Back to Search

Homelessness Diversion for Emergency Department Patients Facing Homelessness

N/A
Waitlist Available
Led By Jack Tsai, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Awards & highlights

Study Summary

This trial investigates whether a homelessness program in a hospital ED can reduce visits & tailor services to meet diverse needs.

Who is the study for?
This trial is for English or Spanish speakers discharged from a Harris Health Hospital ED who are at imminent risk of homelessness and have Medicaid, Medicare, or no insurance. It's not for those with a legal guardian or plans to leave Texas within 6 months.Check my eligibility
What is being tested?
The study is testing if integrating Homelessness Diversion (HD) services into the emergency department discharge process can reduce future ED visits. It compares HD support against the usual treatment patients receive when leaving the hospital.See study design
What are the potential side effects?
Since this trial involves social service interventions rather than medical treatments, traditional side effects are not applicable. However, there may be varying personal experiences with the diversion program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 1, month 2, month 3, month 4, month 5 and month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 1, month 2, month 3, month 4, month 5 and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of ED visits
Secondary outcome measures
Change in health related quality of life as assessed by the Short Form-12 version 2.0 (SF12v2) health Survey
Number of participants who experience homelessness

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Homeless diversion (HD) groupExperimental Treatment1 Intervention
Group II: Treatment-as-usual (TAU) groupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
319,977 Total Patients Enrolled
1 Trials studying Homelessness
40 Patients Enrolled for Homelessness
National Institute on Minority Health and Health Disparities (NIMHD)NIH
382 Previous Clinical Trials
1,215,161 Total Patients Enrolled
Jack Tsai, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Treatment-as-usual (TAU) Clinical Trial Eligibility Overview. Trial Name: NCT05823220 — N/A
Homelessness Research Study Groups: Homeless diversion (HD) group, Treatment-as-usual (TAU) group
Homelessness Clinical Trial 2023: Treatment-as-usual (TAU) Highlights & Side Effects. Trial Name: NCT05823220 — N/A
Treatment-as-usual (TAU) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05823220 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can new patients still enroll in this experiment?

"Unfortunately, the records available on clinicaltrials.gov indicate that this trial is not presently enrolling patients. Initially posted in May of 2023 and last modified on April 8th, there are no current openings here; however, 213 other trials are currently taking applicants."

Answered by AI
~588 spots leftby Mar 2025